Stephane Minvielle

Stephane Minvielle

UNVERIFIED PROFILE

Are you Stephane Minvielle?   Register this Author

Register author
Stephane Minvielle

Stephane Minvielle

Publications by authors named "Stephane Minvielle"

Are you Stephane Minvielle?   Register this Author

52Publications

1715Reads

31Profile Views

The effects of MicroRNA deregulation on pre-RNA processing network in multiple myeloma.

Leukemia 2019 Jun 10. Epub 2019 Jun 10.

Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0498-5DOI Listing
June 2019

Constraints on signaling network logic reveal functional subgraphs on Multiple Myeloma OMIC data.

BMC Syst Biol 2018 03 21;12(Suppl 3):32. Epub 2018 Mar 21.

LS2N, UMR 6004, École Centrale de Nantes, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12918-018-0551-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872385PMC
March 2018

Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome.

J Clin Oncol 2016 06 25;34(18):2125-32. Epub 2016 Apr 25.

Bruno Royer, Momar Diouf, and Jean Pierre Marolleau, University Hospital, Amiens; Stéphane Minvielle and Philippe Moreau, University Hospital; Stéphane Minvielle, Institut National de la Santé et de la Recherche Médicale U892, Nantes; Murielle Roussel and Hervé Avet-Loiseau, Institute Universitaire du Cancer de Toulouse Oncopole; Hervé Avet-Loiseau, University Hospital, Toulouse; Lionel Karlin, University Hospital, Lyon; Cyrille Hulin, University Hospital, Vandœuvre lès Nancy; Bertrand Arnulf, St Louis University Hospital; Laurent Frenzel, Necker University Hospital; Laurent Garderet, St Antoine University Hospital; Sylvain Choquet, La Pitié University Hospital, Paris; Margaret Macro, University Hospital, Caen; Sylvie Cailleres, General Hospital, Aix en Provence; Annie Brion, University Hospital, Besançon; Sabine Brechignac, University Hospital, Bobigny; Karim Belhadj, University Hospital, Creteil; Marie Lorraine Chretien, University Hospital, Dijon; Marc Wetterwald, General Hospital, Dunkerque; Carine Chaleteix, University Hospital, Clermont-Ferrand; Mourad Tiab, General Hospital, La Roche/Yon; Xavier Leleu, University Hospital, Poitiers; Jean Gabriel Fuzibet, University Department, Nice; Charles Dauriac, University Hospital, Rennes; Luc-Matthieu Forneker, University Hospital, Strasbourg; Lotfi Benboubker, University Hospital, Tours; and Thierry Facon, University Hospital, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.1929DOI Listing
June 2016

MB4-2 breakpoint in MMSET combined with del(17p) defines a subset of t(4;14) multiple myeloma with very poor prognosis.

Haematologica 2015 Nov 23;100(11):e471-4. Epub 2015 Jul 23.

Immuno-Hematology, Saint-Louis Hospital, Paris, France Université Paris Diderot, Sorbonne Paris Cité, Paris, France INSERM UMR 1126 Institut Universitaire d'Hématologie, Paris, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.127001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825293PMC
November 2015

Differential and limited expression of mutant alleles in multiple myeloma.

Blood 2014 Nov 18;124(20):3110-7. Epub 2014 Sep 18.

Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Department of Hematology/Oncology, Boston Veterans Administration Healthcare System, West Roxbury, MA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-04-569327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231420PMC
November 2014

Identification of human leucocyte antigen (HLA)-A*0201-restricted cytotoxic T lymphocyte epitopes derived from HLA-DOβ as a novel target for multiple myeloma.

Br J Haematol 2013 Nov 30;163(3):343-51. Epub 2013 Aug 30.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Cancer Vaccine Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Department of Biomedical Science, Jungwon University, Chungcheongbuk-do, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12544DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137325PMC
November 2013

Cereblon expression in multiple myeloma: not ready for prime time.

Br J Haematol 2013 Oct 17;163(2):282-4. Epub 2013 Jul 17.

Haematology Laboratory, University Hospital, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12478DOI Listing
October 2013

The shaping and functional consequences of the dosage effect landscape in multiple myeloma.

BMC Genomics 2013 Oct 2;14:672. Epub 2013 Oct 2.

Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2164-14-672DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907079PMC
October 2013

Pathway-based identification of SNPs predictive of survival.

Eur J Hum Genet 2011 Jun 2;19(6):704-9. Epub 2011 Feb 2.

Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ejhg.2011.3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110054PMC
June 2011

Molecular heterogeneity of multiple myeloma: pathogenesis, prognosis, and therapeutic implications.

J Clin Oncol 2011 May 11;29(14):1893-7. Epub 2011 Apr 11.

University Hospital, Institut National de la Santé et de la Recherche Médicale U892, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.32.8435DOI Listing
May 2011

The dChip survival analysis module for microarray data.

BMC Bioinformatics 2011 Mar 9;12:72. Epub 2011 Mar 9.

Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, 450 Brookline Ave, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2105-12-72DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068974PMC
March 2011

Prognostic significance of copy-number alterations in multiple myeloma.

J Clin Oncol 2009 Sep 17;27(27):4585-90. Epub 2009 Aug 17.

L'Institut National de la Santé et de la Recherche Médicale U892, Université de Nantes, Institut de Biologie, 9 Quai Moncousu, Nantes, 44093, France.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2008.20.6136
Publisher Site
http://dx.doi.org/10.1200/JCO.2008.20.6136DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754906PMC
September 2009

Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen.

Breast Cancer Res Treat 2008 Jun 21;109(3):491-501. Epub 2007 Jul 21.

Service d'Oncologie Médicale, Centre de Lutte Contre le Cancer René Gauducheau, Bd J. Monod, 44805, Nantes-Saint Herblain Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-007-9673-xDOI Listing
June 2008

Gene Expression Profiles Discriminate between Pathological Complete Response and Resistance to Neoadjuvant FEC100 in Breast Cancer.

Cancer Genomics Proteomics 2006 Mar-Apr;3(2):89-95. Epub 2006 Mar 1.

Département de Biologie Oncologique, Centre de Lutte Contre le Cancer René Gauducheau, Bd J. Monod, 44805 Nantes - Saint Herblain Cedex

View Article

Download full-text PDF

Source
March 2006

[Gene expression profiling of multiple myeloma].

Bull Cancer 2003 Feb;90(2):127-30

Inserm U463, Institut de Biologie, 9, quai Moncousu, 44035 Nantes Cedex.

View Article

Download full-text PDF

Source
February 2003